{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-099389","form_type":"8-K","ticker":"AXSM","cik":"0001579428","company_name":"Axsome Therapeutics, Inc.","filed_at":"2024-08-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.617031+00:00","generated_at":"2026-05-31T08:14:59.972696+00:00","sec_items":["8.01","9.01"],"event_type":"litigation","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Axsome and Sandoz dismiss Sunosi patent litigation; Sandoz withdraws generic ANDA","bullets":["Sandoz withdrew its ANDA for a generic equivalent of Sunosi (solriamfetol), leading to dismissal of patent litigation without prejudice.","Litigation was pending in U.S. District Court for the District of New Jersey.","Dismissal removes a potential near-term generic threat to Sunosi, Axsome's CNS product."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-099389","json":"https://secwatch.observer/filing/0000950170-24-099389.json","markdown":"https://secwatch.observer/filing/0000950170-24-099389.md","text":"https://secwatch.observer/filing/0000950170-24-099389.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1579428/000095017024099389/0000950170-24-099389-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1579428/000095017024099389/axsm-20240821.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:14:59.972696+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}